24Fév202024 février 2020 Press Release, Ixaltis – Completion of Scientific Advice and End-of-Phase 2 interactions with EMA and FDA respectively, February 2020Read More
02Oct20192 octobre 2019 Press Release, Ixaltis – Positive Results from phase 2 studies for Litoxetine, October 2019Read More
14Mai201914 mai 2019 Press Release, Ixaltis-Successful Completion of phase 2 for Litoxetine, May 2019Read More
09Juil201819 juillet 2018 Press Release, Ixaltis-Completion of recruitment in EU/Canada, July 2018Read More
27Fév201728 juillet 2017 Abstract 2/2 EAU 2017 – Effects of litoxetine on acetic acid-inducedRead More
